Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?-Reference-Cited by-同舟云学术

Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?

Published:2018-02-13 Issue:5 Volume:25 Page:601-605
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Hertelendy Johannes¹,Reumuth Georg²,Simons David¹,Stoppe Christian³,Kim Bong-Sung¹,Stromps Jan-Philipp¹,Fuchs Paul C.⁴,Bernhagen Jurgen⁵,Pallua Norbert¹,Grieb Gerrit¹

Affiliation:

1. Department of Plastic Surgery and Hand Surgery, Burn Center, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany

2. Department of Plastic Surgery and Hand Surgery, Gemeinschaftskrankenhaus Havelhoehe, Teaching Hospital of the Charité Berlin, Kladower Damm 221, 14089 Berlin, Germany

3. Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany

4. Department of Plastic Surgery and Hand Surgery, Burn Center, University of Witten/ Herdecke, Ostmerheimerstrasse 200, 51109 Cologne, Germany

5. Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Strasse 17, 81377 Munich, Germany

Abstract

Background: Macrophage migration inhibitory factor (MIF) was firstly described in the 1960s as a pleiotropic cytokine affecting a variety of immune cells. Different physiological functions mainly involving inflammatory reactions such as chemokine-like function and regulating systemic stress responses have been reported. Objective: In several clinical studies the use of MIF as a biomarker has been investigated promising support for diseases with an inflammatory aspect such as sepsis, systemic infections and autoimmune diseases. This article in detail reviews clinical data and evaluates the function as biomarker focusing on inflammatory and autoimmune diseases. Conclusion: Recent studies suggest MIF to be a marker for different inflammatory diseases and might serve as therapeutic target in the future.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Serum Macrophage Migration Inhibitory Factor with 3-Month Poor Outcome and Malignant Cerebral Edema in Patients with Large Hemispheric Infarction;Neurocritical Care;2024-04-01

2. Advances in research on the anti-tumor mechanism of Astragalus polysaccharides;Frontiers in Oncology;2024-03-06

3. Circulating inflammatory cytokines and hypertensive disorders of pregnancy: a two-sample Mendelian randomization study;Frontiers in Immunology;2023-11-16

4. Association of serum macrophage migration inhibitory factor with large hemisphere infarction and malignant cerebral edema after acute ischemic stroke;2022-12-16

5. D‐dopachrome tautomerase in cardiovascular and inflammatory diseases—A new kid on the block or just another MIF ?;The FASEB Journal;2022-10-21